InvestorsHub Logo
Replies to #91499 on Biotech Values
icon url

swampboots

03/02/10 10:49 PM

#91531 RE: DewDiligence #91499

I have a gut feeling these kinds of customized expensive tests will be normalized for almost all cancer testing, and> ......... <in a fictional world, a philanthropic czar would match all the maladies with possible remedies, and for a start, would
pour billions of his own money to combat those mutating malignancies, according to his own superb memory of everything that has ever been published in those fields
icon url

genisi

03/03/10 3:34 AM

#91562 RE: DewDiligence #91499

Myriad has indicated the launch of 2 new molecular diagnostic products in 2010, so the next one will probably be a pancreatic cancer test (they have mentioned a pancreatic cancer gene they will probably combine with BRCA2 and P16).
icon url

dewophile

03/04/10 4:31 PM

#91733 RE: DewDiligence #91499

MYGN

the real money might be if this test can help triage those who should get treatment or just hightened surveillance after a biopsy given the high proportion of indolent prostate cancers